HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Davide Prosperi Selected Research

Nanoconjugates

11/2018Half-Chain Cetuximab Nanoconjugates Allow Multitarget Therapy of Triple Negative Breast Cancer.
7/2017Nano-targeting of mucosal addressin cell adhesion molecule-1 identifies bowel inflammation foci in murine model.
1/2017Development of 99mTc-radiolabeled nanosilica for targeted detection of HER2-positive breast cancer.
1/2016"Blind" targeting in action: From phage display to breast cancer cell targeting with peptide-gold nanoconjugates.
4/2015Peptide-nanoparticle ligation mediated by cutinase fusion for the development of cancer cell-targeted nanoconjugates.
8/2014Development of U11-functionalized gold nanoparticles for selective targeting of urokinase plasminogen activator receptor-positive breast cancer cells.
1/2014Biotechnological approaches toward nanoparticle biofunctionalization.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Davide Prosperi Research Topics

Disease

37Neoplasms (Cancer)
11/2021 - 03/2010
17Breast Neoplasms (Breast Cancer)
11/2021 - 11/2009
4Neoplasm Metastasis (Metastasis)
01/2021 - 03/2010
4Hyperthermia
11/2020 - 12/2016
3Triple Negative Breast Neoplasms
01/2021 - 10/2017
3Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
01/2020 - 07/2017
2Bronchiolitis Obliterans Syndrome
11/2020 - 05/2017
2Glioblastoma (Glioblastoma Multiforme)
11/2020 - 10/2018
1Arthritis (Polyarthritis)
01/2021
1Virus Diseases (Viral Diseases)
01/2021
1COVID-19
01/2021
1Hemolysis
12/2020
1Necrosis
11/2020
1Cognitive Dysfunction
11/2020
1Dementia (Dementias)
11/2020
1Brain Neoplasms (Brain Tumor)
11/2020
1Neurodegenerative Diseases (Neurodegenerative Disease)
07/2020
1Systemic Scleroderma (Systemic Sclerosis)
01/2019
1Fibrosis (Cirrhosis)
01/2019
1Malignant Mesothelioma
01/2019
1Carcinoma (Carcinomatosis)
10/2018
1Dehydration (Water Stress)
07/2018
1Obesity
12/2017
1Rheumatoid Arthritis
12/2017
1Psoriasis (Pustulosis Palmaris et Plantaris)
12/2017
1Colitis
07/2017
1Inflammation (Inflammations)
07/2017
1Cardiotoxicity
01/2017
1Communicable Diseases (Infectious Diseases)
01/2017
1Infections
01/2017
1Prostatic Neoplasms (Prostate Cancer)
12/2016
1Frontotemporal Dementia (Semantic Dementia)
04/2016
1Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker)
01/2015

Drug/Important Bio-Agent (IBA)

11Pharmaceutical PreparationsIBA
03/2021 - 08/2014
9Proteins (Proteins, Gene)FDA Link
01/2021 - 08/2010
9GoldIBA
01/2019 - 09/2012
7ApoferritinsIBA
11/2021 - 12/2014
7NanoconjugatesIBA
11/2018 - 01/2014
6AntibodiesIBA
03/2021 - 10/2010
6human ERBB2 proteinIBA
01/2021 - 08/2010
6Peptides (Polypeptides)IBA
01/2021 - 03/2013
5Monoclonal AntibodiesIBA
11/2018 - 08/2010
5Trastuzumab (Herceptin)FDA Link
01/2018 - 08/2010
5LigandsIBA
04/2015 - 03/2010
4Contrast MediaIBA
11/2021 - 11/2009
4Doxorubicin (Adriamycin)FDA LinkGeneric
03/2021 - 12/2014
4Biological ProductsIBA
05/2018 - 08/2010
3Transferrin Receptors (Transferrin Receptor)IBA
11/2021 - 10/2020
3Silicon Dioxide (Silica)FDA LinkGeneric
01/2021 - 11/2011
3PolymersIBA
12/2020 - 03/2013
3CurcuminIBA
11/2020 - 03/2013
3AntigensIBA
12/2017 - 11/2011
2SolutionsIBA
06/2021 - 08/2010
2Imatinib Mesylate (Gleevec)FDA Link
11/2020 - 01/2019
2DisulfidesIBA
10/2020 - 08/2010
2Biomarkers (Surrogate Marker)IBA
01/2016 - 10/2014
1MetalsIBA
11/2021
1IonsIBA
11/2021
1Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA
01/2021
1liposomal doxorubicin (Doxil)FDA Link
01/2021
1ZincIBA
11/2020
1Glutathione (Reduced Glutathione)IBA
10/2020
1LuciferinsIBA
10/2020
1Ferritins (Ferritin)IBA
10/2020
1alpha-SynucleinIBA
07/2020
1Amyloidogenic ProteinsIBA
07/2020
1Polylactic Acid-Polyglycolic Acid CopolymerIBA
12/2019
1Paclitaxel (Taxol)FDA LinkGeneric
12/2019
1Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric
12/2019
1Pemetrexed (MTA)FDA Link
01/2019
1Bleomycin (Blenoxane)FDA LinkGeneric
01/2019
1Cetuximab (Erbitux)FDA Link
11/2018
1ClathrinIBA
10/2018
1EcdysteroidsIBA
05/2018
1LipidsIBA
12/2017
1S-methyl homocysteine thiolactoneIBA
12/2017
1manganese oxide (hausmannite)IBA
07/2017
1Cell Adhesion Molecule-1IBA
07/2017
1Reactive Oxygen Species (Oxygen Radicals)IBA
01/2017
1CosmeticsIBA
01/2017
1Anti-Infective Agents (Microbicides)IBA
01/2017
1colloidal silverIBA
01/2017
1Drug CarriersIBA
01/2017
1ParabensIBA
01/2017
1Neuropeptide Y Receptors (Neuropeptide Y Receptor)IBA
12/2016
1Neuropeptide YIBA
12/2016
1ProgranulinsIBA
04/2016
1Peptide LibraryIBA
01/2016
1cutinaseIBA
04/2015

Therapy/Procedure

12Therapeutics
03/2021 - 08/2010
3Precision Medicine
11/2020 - 12/2016
2Drug Therapy (Chemotherapy)
03/2021 - 01/2017
2Lasers (Laser)
12/2016 - 04/2015
1Intravenous Administration
01/2021
1Quantum Dots (Quantum Dot)
01/2020
1Immunotherapy
01/2020
1Photochemotherapy (Photodynamic Therapy)
01/2019
1Lung Transplantation
05/2017
1Photothermal Therapy
12/2016
1Ligation
04/2015